Literature DB >> 31860127

Diagnostic strategy for females suspected of Fabry disease.

Sukirthini Balendran1, Petra Oliva2, Stefaan Sansen3, Thomas P Mechtler2, Berthold Streubel1, Paulina N Cobos4, Zoltan Lukacs4, David C Kasper2.   

Abstract

A total of 11 948 females suspicious of Fabry disease were tested by a combined biochemical and genetic approach. The enzyme activity, together with the concentration of lyso-GL-3 (lyso-Gb3) biomarker in dried blood spots (DBS), substantially improved the diagnostic detection of Fabry disease in females compared to the enzyme activity alone. Abnormal values for both were highly suspicious of Fabry disease (97% positive predictive value [PPV], similar to PPV in males). In cases with one abnormal biochemical value, elevated lyso-GL-3 is a far more important indicator than low enzyme activity (39% PPV vs 6% PPV). Cases with clearly negative results for both biochemical parameters are unlikely to have Fabry disease, even in clinically highly suspicious cases.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FD diagnosis; Fabry disease; biomarkers; lyso-GL-3; α-galactosidase

Mesh:

Substances:

Year:  2020        PMID: 31860127     DOI: 10.1111/cge.13694

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.

Authors:  K Savostyanov; A Pushkov; I Zhanin; N Mazanova; S Trufanov; A Pakhomov; A Alexeeva; D Sladkov; A Asanov; A Fisenko
Journal:  Orphanet J Rare Dis       Date:  2022-05-16       Impact factor: 4.303

2.  Brazilian consensus recommendations for the diagnosis, screening, and treatment of individuals with fabry disease: Committee for Rare Diseases - Brazilian Society of Nephrology/2021.

Authors:  Cassiano Augusto Braga Silva; Luis Gustavo Modelli de Andrade; Maria Helena Vaisbich; Fellype de Carvalho Barreto
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

Review 3.  Renal Manifestations of Fabry Disease: A Narrative Review.

Authors:  Cassiano Augusto Braga Silva; José A Moura-Neto; Marlene Antônia Dos Reis; Osvaldo Merege Vieira Neto; Fellype Carvalho Barreto
Journal:  Can J Kidney Health Dis       Date:  2021-01-19

4.  Multidisciplinary approach to screening and management of children with Fabry disease: practice at a Tertiary Children's Hospital in China.

Authors:  Qian Shen; Jialu Liu; Jing Chen; Shuizheng Zhou; Yi Wang; Lifei Yu; Li Sun; Liuhui Wang; Bingbing Wu; Fang Liu; Yun Cao; Ying Huang; Jianshe Wang; Chenhao Yang; Daqian Zhu; Yangyang Ma; Zhengmin Xu; Wei Lu; Lili Fu; Wenhao Zhou; Hong Xu
Journal:  Orphanet J Rare Dis       Date:  2021-12-14       Impact factor: 4.123

5.  Pulmonary manifestations and the effectiveness of enzyme replacement therapy in Fabry Disease with the p. Arg227Ter (p.R227*) mutation.

Authors:  Päivi Pietilä-Effati; Johan Söderström; Jukka T Saarinen; Eliisa Löyttyniemi; Ilkka Kantola
Journal:  Mol Genet Genomic Med       Date:  2022-03-04       Impact factor: 2.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.